BCL3 and colorectal carcinoma: This was supported by in vivo studies using BCL3-knockout mice subjected to gamma irradiation or the DNA damage inducing agent cisplatin to demonstrate that intestinal crypts also exhibited increased γH2AX foci and increased cleaved-caspase 3 (CC3) and an increased sensitivity of transgenic CRC mice to chemotherapy in the absence of BCL3.